We are live on
!
Find out more
SR
Summer Road Portfolio holdings
AUM
$161M
1-Year Est. Return
27.24%
This Fund
S&P 500
This Quarter
Est. Return
-28.98%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$29.4M
AUM Growth
-$10.8M
(-27%)
Cap. Flow
+$998K
Cap. Flow
% of AUM
3.39%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ocular Therapeutix
OCUL
|
+$998K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SFCM
LWM
MWM
MCM
BFS
MMCM
MWA
BWM
Summer Road's Q1 2022 Portfolio in Review
As of Q1 2022, Summer Road held 1 position worth $29.4M, down 27% from $40.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Summer Road deployed $998K of net new capital in Q1 2022, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Summer Road added most to Ocular Therapeutix in Q1 2022, an estimated $998K increase.
- Summer Road's ten largest holdings make up 100% of its $29.4M portfolio in Q1 2022.
- Summer Road opened 0 new positions and closed 0 in Q1 2022.
- Summer Road's portfolio value fell 27% quarter-over-quarter to $29.4M.
Based on Summer Road's 13F filing for Q1 2022, filed 13 May 2022.